Top Oncology Pharmaceutical Companies 2025

Top Oncology Pharmaceutical Companies 2025. Top Pharmaceutical Companies 2024 Berna Trudey Amunix is an immuno-oncology company focused on developing immune-activating biotherapeutics for patients with solid tumor cancers. Till date, the sector has seen the creation of 20 Unicorns

Best Pharmaceutical Etf 2025 Rebecca Dillon
Best Pharmaceutical Etf 2025 Rebecca Dillon from rebeccaldillon.pages.dev

United States has the most number of companies in Oncology (3,039), followed by China (444), and then United Kingdom (345). Amunix is an immuno-oncology company focused on developing immune-activating biotherapeutics for patients with solid tumor cancers.

Best Pharmaceutical Etf 2025 Rebecca Dillon

Detailed info and reviews on 100 top Oncology companies and startups in 2025 The cast of characters is largely the same, and Roche, Celgene and Bristol-Myers Squibb—which took the top three spots last year—are projected by EvaluatePharma to rank 1-2-3 six years from now, too. Amunix is an immuno-oncology company focused on developing immune-activating biotherapeutics for patients with solid tumor cancers.

Best Pharmaceutical Etf 2025 Rebecca Dillon. Note: Columns 1 and 2 represent ranks and companies, while Columns 3, 4, and 5 showcase the total Oncology revenue of 2022, the total revenue of 2023, and the percentage change There are 6,188 companies in Oncology which include Guardant Health, BeiGene, Jazz Pharmaceuticals, Moderna, RefleXion

Ranking Pharmaceutical Companies 2024 Catlin Joellen. 4,125 companies in Oncology are funded, with 2,397 having secured Series A funding At first glance, the list of cancer drug makers predicted to head the field by 2024 may not look so different from the list of top-selling cancer drug makers in 2017